I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Shcheblyakov, Dmitry V
72
results:
Search for persons
X
Format
Online (72)
Mediatypes
Articles (Online) (42)
OpenAccess-fulltext (30)
Sorted by: Relevance
Sorted by: Year
?
1
Structural Basis for Evasion of New SARS-CoV-2 Variants fro..:
Sluchanko, Nikolai N.
;
Shcheblyakov, Dmitry V.
;
Varfolomeeva, Larisa A.
...
Biochemistry (Moscow). 89 (2024) 7 - p. 1260-1272 , 2024
Link:
https://doi.org/10.1134/..
?
2
Real-world clinical effectiveness of Tixagevimab/Cilgavimab..:
Fomina, Daria S.
;
Lebedkina, Marina S.
;
Iliukhina, Anna A.
...
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
3
Safety and immunogenicity of rAd26 and rAd5 vector-based he..:
Tukhvatulin, Amir I.
;
Dolzhikova, Inna V.
;
Dzharullaeva, Alina S.
...
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
4
rAAV expressing recombinant antibody for emergency preventi..:
Esmagambetov, Ilias B.
;
Ryabova, Ekaterina I.
;
Derkaev, Artem A.
...
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
5
Single-domain antibody delivery using an mRNA platform prot..:
Panova, Eugenia A.
;
Kleymenov, Denis A.
;
Shcheblyakov, Dmitry V.
...
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
6
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 ..:
Favorskaya, Irina A.
;
Shcheblyakov, Dmitry V.
;
Esmagambetov, Ilias B.
...
Frontiers in Immunology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
7
Retention of Neutralizing Response against SARS-CoV-2 Omicr..:
Lapa, Daniele
;
Grousova, Daria M.
;
Matusali, Giulia
...
Vaccines. 10 (2022) 5 - p. 817 , 2022
Link:
https://doi.org/10.3390/..
?
8
Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemaggl..:
Voronina, Daria V.
;
Shcheblyakov, Dmitry V.
;
Favorskaya, Irina A.
...
Viruses. 14 (2022) 11 - p. 2485 , 2022
Link:
https://doi.org/10.3390/..
?
9
rAAV expressing recombinant neutralizing antibody for the b..:
Derkaev, Artem A.
;
Ryabova, Ekaterina I.
;
Esmagambetov, Ilias B.
...
Frontiers in Microbiology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
10
Immunogenicity and protectivity of intranasally delivered v..:
Tukhvatulin, Amir I.
;
Gordeychuk, Ilya V.
;
Dolzhikova, Inna V.
...
Emerging Microbes & Infections. 11 (2022) 1 - p. 2229-2247 , 2022
Link:
https://doi.org/10.1080/..
?
11
Estimation of anti-orthopoxvirus immunity in Moscow residen..:
Gushchin, Vladimir A.
;
Ogarkova, Darya A.
;
Dolzhikova, Inna V.
...
Frontiers in Immunology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
12
Sputnik V protection from COVID-19 in people living with HI..:
Gushchin, Vladimir A.
;
Tsyganova, Elena V.
;
Ogarkova, Darya A.
...
eClinicalMedicine. 46 (2022) - p. 101360 , 2022
Link:
https://doi.org/10.1016/..
?
13
Revaccination in Age-Risk Groups with Sputnik V Is Immunolo..:
Godkov, Mikhail A.
;
Ogarkova, Darya A.
;
Gushchin, Vladimir A.
...
Vaccines. 11 (2022) 1 - p. 90 , 2022
Link:
https://doi.org/10.3390/..
?
14
An open, non-randomised, phase 1/2 trial on the safety, tol..:
Tukhvatulin, Amir I.
;
Dolzhikova, Inna V.
;
Shcheblyakov, Dmitry V.
...
The Lancet Regional Health - Europe. 11 (2021) - p. 100241 , 2021
Link:
https://doi.org/10.1016/..
?
15
Neutralizing Activity of Sera from Sputnik V-Vaccinated Peo..:
Gushchin, Vladimir A.
;
Dolzhikova, Inna V.
;
Shchetinin, Alexey M.
...
Vaccines. 9 (2021) 7 - p. 779 , 2021
Link:
https://doi.org/10.3390/..
1-15